← Eichor
Condition: Pmn Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Pmn

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
Phase 3 · 31 location(s) · Cerium Pharmaceuticals, Inc. · NCT05696613Evaluation of the Use of Granulocyte Colony Stimulating Factor (GCSF) in Post Kasai Type 3 Biliary Atresia
NA · 1 location(s) · National Liver Institute, Egypt · NCT06708572Efficacy of Recombinant Human G-CSF in Women With Unexplained Recurrent Miscarriage
Phase 2 · 1 location(s) · Fakih IVF Fertility Center · NCT07724405A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
Phase 1/Phase 2 · 19 location(s) · Nkarta, Inc. · NCT06557265CHRONO-MOBILIZE: Chronotherapy of G-CSF for CD34+ Mobilization in Healthy Donors
NA · 3 location(s) · First Affiliated Hospital of Zhejiang University · NCT07423728A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy
Phase 2 · 43 location(s) · Climb Bio, Inc. · NCT07096843Clinical Trial Protocol for the Combined Use of VAG in the Treatment of ND-AML
NA · 1 location(s) · Yang Xiaotian · NCT06536010A Clinical Study of Albumin-bound Paclitaxel/Granulocyte-based Therapy for Recurrent/Metastatic Breast Cancer
NA · 2 location(s) · JIANG LONGWEI · NCT06496724Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS)
Phase N/A · 1 location(s) · Northwell Health · NCT07186179Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00001405Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilizat
EARLY_Phase 1 · 2 location(s) · Rutgers, The State University of New Jersey · NCT04211259OH2 Oncolytic Viral Therapy in Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Binhui Biopharmaceutical Co., Ltd. · NCT03866525CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
Phase 2 · 1 location(s) · University of Maryland, Baltimore · NCT04050280Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers
NA · 1 location(s) · Alexandria University · NCT07300735Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pM
Phase 2/Phase 3 · 108 location(s) · Vertex Pharmaceuticals Incorporated · NCT07204275A Real World Study About PMN
Phase N/A · 1 location(s) · Wei Chen · NCT06893328Effect of Single vs Repeated Cycles of a Combination of Granulocyte Colony Stimulating Factor and Darbepoetin vs Standar
NA · 1 location(s) · Institute of Liver and Biliary Sciences, India · NCT07002827Study of WAL0921 in Patients With Glomerular Kidney Diseases
Phase 2 · 50 location(s) · Walden Biosciences · NCT06466135Improving White Blood Cell Collection From Healthy Donors
Phase 4 · 1 location(s) · National Institutes of Health Clinical Center (CC) · NCT01553214Loratadine for the Prevention of G-CSF-related Bone Pain
Phase 2 · 1 location(s) · AHS Cancer Control Alberta · NCT05421416RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis
EARLY_Phase 1 · 1 location(s) · Yana Najjar · NCT06216938Atacicept in Multiple Glomerular Diseases
Phase 2 · 1 location(s) · Vera Therapeutics, Inc. · NCT06983028Cadonilimab Plus Anlotinib for R/M/P Cervical Cancer
Phase 2 · 1 location(s) · Zhongnan Hospital · NCT05817214Assessment of Salivary GM-CSF, MIP, and IL-1β Levels in Subjects With Varying Periodontal Conditions
Phase N/A · 1 location(s) · Izmir Katip Celebi University · NCT06961409NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05189925Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT00001529A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · 104 location(s) · Biogen · NCT06962800Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
Phase 2 · 40 location(s) · Alexion Pharmaceuticals, Inc. · NCT07157787Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of
Phase 4 · 3 location(s) · Ottawa Hospital Research Institute · NCT05753618G-CSF After Chemo-radiation in Patients With Glioblastoma
Phase 2 · 1 location(s) · Massachusetts General Hospital · NCT06649851
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.